Focus10TH ANNIVERSARY SERIES
Promising disease-modifying therapies for Parkinson’s disease
- Valina L. Dawson1,2,3,4,* and
- Ted M. Dawson1,2,3,5,*
- 1Neuroregeneration and Stem Cell Programs, Institute for Cell Engineering, Johns Hopkins University School of Medicine, Baltimore, MD 21205, USA.
- 2Department of Neurology, Johns Hopkins University School of Medicine, Baltimore, MD 21205, USA.
- 3Solomon H. Snyder Department of Neuroscience, Johns Hopkins University School of Medicine, Baltimore, MD 21205, USA.
- 4Department of Physiology, Johns Hopkins University School of Medicine, Baltimore, MD 21205, USA.
- 5Department of Pharmacology and Molecular Sciences, Johns Hopkins University School of Medicine, Baltimore, MD 21205, USA.
- ↵*Corresponding author. Email: vdawson{at}jhmi.edu (V.L.D.); tdawson{at}jhmi.edu (T.M.D.)
See allHide authors and affiliations
Science Translational Medicine 27 Nov 2019:
Vol. 11, Issue 520, eaba1659
DOI: 10.1126/scitranslmed.aba1659
